Ongoing Disparagement Investigation *–* European Commission Discloses Additional Details of its Case and Sanofi Proposes Commitments News
European Commission Opens First Formal Abuse of Dominance Investigation in Medical Devices Sector News
Lithuanian Competition Authority Fines Pharmacy Association and Individual Firms for Collusion while Participating in Margin*-*setting Procedure Briefings
Court of Justice of European Union Rules that Pay-for-Delay Patent Settlements May Restrict Competition 'by Object' News
Complaint by Greek Medicine Wholesaler Against Switch to Direct Distribution Dismissed by European Commission News
European Commission Opens Competition Procedure Against Sanofi Over Communications Campaign Regarding Flu Vaccines News
France *-* Supreme Court Allows Follow*-*on Damages Action by Health Insurer in Wake of Sanofi's Denigration Strategy against Generic Rivals Briefings
European Commission Sends Statement of Objections to Teva over Abusive Patent Filings and Disparagement of Generic Competitors Briefings
F. Hoffmann*-*La Roche and Novartis (Avastin *-* Lucentis) *–* ECJ Finds Concerted Efforts to Restrict Off*-*label Use of Medicinal Products Likely to Breach Competition Rules Briefings
Advocate General Recommends to Court of Justice of European Union to Allow Reimbursement of Off Label Use of Medicine for Purely Budgetary Reasons Briefings
"National Healthcare Insurance Systems Are Allowed To Reimburse Off*-*Label Use of Medicine" Says ECJ Briefings
French Competition Authority *-* Genentech, Novartis and Roche Fined EUR 444 million in Saga Involving Wet Age*-*Related Macular Degeneration Briefings
Court of Justice of European Union Rules that Pay*-*for*-*Delay Patent Settlements May Restrict Competition 'by Object' Briefings
General Court Reviews New Set of Patent Settlement Agreements In Pharmaceutical Sector (Servier and Others) Briefings
European Commission Opens Investigation into Teva over Suspected Abusive Patent Filings and Disparagement of Generic Competitors Briefings
French Competition Authority Fines Johnson & Johnson EUR 25 million for Hampering Market Entry of Generic Rivals Briefings
French Supreme Court rejects appeal and upholds competition law decision against Janssen Cilag for strategies against entry of generic competitors Briefings
European Commission Starts Competition Investigation against Vifor Pharma regarding Disparaging Statements Made against Rival's Medicine Briefings
European Commission Proposes Overhaul of Regulatory and Intellectual Property Framework Governing Pharmaceuticals Briefings
Advocate General Szpunar Makes Questionable Proposal to Relax Language Requirements for Labelling of Parallel*-*Traded Medicinal Products News
Court of Justice of European Union Defines Limits of Distributors' Due Care Obligations Under Medical Devices Regulation News
Alleged Anticompetitive Bundling of MS Treatment & Diagnostic *–* Italian Competition Authority Investigates Biogen Briefings
USTR Places EU on 2026 Special 301 Watch List for Failure to Give Adequate Protection to Innovative Medicines News
CJEU Rules that EU Member States Cannot Restrict Online Sale of Non*-*Prescription Medicinal Products to Single Subcategory on Public Health Grounds Briefings
EU Pharmaceutical Package | Part I *–* Regulatory Data & Market Protection, Orphan Market Exclusivity, Bolar Exemption and Antimicrobial Vouchers Briefings
Court of Justice of European Union Clarifies Scope of Officinal Formula Exemption Under EU Medicinal Product Law Briefings
VBB competition and life sciences experts published in the Tijdschrift voor Belgisch Handelsrecht News
Belgium *-* Publication of Rules of Procedure of Committee for Borderline Products for Human Use Briefings
As Part of its Enforcement Priorities for 2026 Belgian Competition Authority Again Focuses on Healthcare Briefings
European Commission Ends Investigation of Edwards Lifesciences *–* Leaving Many Open Questions Briefings
Is that a threat? No, We’re just stating a fact *-* When does joint lobbying violate EU competition law? Briefings
Hungarian Competition Authority Pursues Several Members of the Supply Chain for Over*-*the*-*Counter Medicines Briefings
Belgian Competition Authority Accuses IQVIA of Abusive Behaviour Involving Pharmaceutical Data Briefings
UK Competition and Markets Authority Removes Competition Law Barriers to Availability of Combination Therapies Briefings
Belgium - Royal Decree Reins In Prescriptions for GLP-1 Analogues to Protect Diabetes Patients and Other Patients in Need Briefings
Data-based Study Quantifies Adverse Impact on Innovation and Market Access of Key Aspects of EU Pharmaceutical Package Briefings
Spain and the Netherlands - Competition Authorities Begin and End Inquiries in Pharmaceutical Industry Briefings
Council and European Parliament Strike Deal on Proposed Regulation on Substances of Human Origin Briefings
Belgium - EU Public Procurement Threshold Applicable to Medicine and Medical Device Purchases by Hospitals Increases Slightly Briefings
Health Emergency Preparedness and Response Authority Calls on Diverse Parties to Join Critical Medicines Alliance Briefings
Pharmaceuticals – New European Commission Report on Competition Law Enforcement (2018-2022) Briefings
Competition and Markets Authority Investigates Vifor over Possibly Misleading Claims regarding Rival's Product Briefings
Council of European Union Approves and Publishes Final Compromise Text of Proposed SoHO Regulation Briefings
Belgian Competition Authority to Secure New Board Member and Amended Procedures but to Lose Competence to Review Hospital Mergers Briefings
Veterinary Medicinal Products - Guidance to Applicants for Marketing Authorisations Under Regulation (EU) 2019/6 Briefings
Belgium - Federal Chamber of Representatives Approves New Law governing Raw Materials Used by Pharmacists Briefings
Belgium - Public Health Insurer Reminds Hospitals of Obligations under Tendering Rules for Biological Medicines Briefings
Court of Justice of European Union Clarifies Rules on Distance Selling of Medicinal Products Not Subject to Medical Prescription Briefings
Spain - Competition Authority Starts Investigation of Loyalty-Inducing Practices towards Pharmacies Briefings
Court of Justice of European Union Clarifies Impartiality Requirements for Experts Consulted by European Medicines Agency Briefings
According to Advocate General Emiliou, Illumina / Grail Transaction Escapes Competence of European Commission Briefings
United States Trade Representative Publishes Annual National Trade Estimate Report on Foreign Trade Barriers and Also Addresses Life Sciences Industry Briefings
European Commission Market Tests Commitments Offered by Vifor Regarding Messaging Involving Intravenous Iron Treatment of Rival Briefings
European Commission and Belgian Presidency of Council of EU Launch Critical Medicines Alliance Briefings
Italian Competition Authority Investigates Alleged Effort by Novartis, Samsung Bioepis, Others to Delay Launch of Biosimilar Version of Ranibizumab Briefings
Belgian Competition Authority Keeps Considering Pharmaceutical Industry As Prime Target for Enforcement Briefings
Italian Competition Authority Ends Cartel Proceedings against Seven Suppliers of Radiopharmaceutical Medicines Briefings
European Commission Pursues Alleged Member of Pharmaceuticals Cartel Following Settlement with Other Cartel Members Briefings
European Commission Accepts Vifor's Commitments Regarding Messaging Involving Rival's Intravenous Iron Treatment and Closes Competition File Briefings
Parallel Trade – Belgian Courts Ban Rebranding of Generic Medicines as Originator Medicines Briefings
European Commission Authorises EUR 2 Billion Aid Package in Support of Nuclear Medicine under European State Aid Rules Briefings
Belgium - Committees for Borderline Products for Human and Veterinary Use Replace Mixed Committee Briefings
Greek Competition Authority Targets Novartis for Alleged Exclusionary Behaviour on Market for Treatment of Macular Diseases Briefings
Court of Justice of European Union Rejects European Commission’s Broad Interpretation of its Merger Review Powers in Landmark Illumina/Grail Judgment Briefings
Draghi Publishes Report on Future of European Competitiveness: EU Pharmaceutical Sector Needs to Bolster Innovation and Improve Intra-EU Coordination Briefings
Advanz Pharma Succeeds in Obtaining Temporary Reprieve of Revocation of Conditional Marketing Authorisation for Ocaliva® Briefings
Mission Letter for Commissioner-designate for Health and Animal Welfare Várhelyi Shows Ambition despite Criticism Briefings
Belgium | Royal Decree of 1 September 2024 Completes Implementation of Regulation (EU) 2019/6 on Veterinary Medicinal products Briefings
Swiss Competition Authority and European Commission Terminate Inquiry Into Novartis Patent Litigation Briefings
Romania - Roche Fails in Attempts to Have Findings of Abusive Behaviour in relation to Oncology Medicines Overturned Briefings
HTA Regulation - Publication of Implementing Regulation containing Rules for Cooperation involving European Commission and European Medicines Agency Briefings
HTA Regulation - European Commission Publishes Implementing Regulation Managing Conflicts of Interest Briefings
European Commission Imposes Heavy Fine on Teva for Misuse of Patent System and Disparaging Rival's Product Briefings
New Study Recommends Increased Scrutiny of R&D Collaborations, Licensing Agreements and M&A Transactions in the Pharmaceutical Sector Briefings
UK Competition Appeal Tribunal quashes CMA’s excessive pricing decision against Pfizer and Flynn, but still finds abuse Briefings
HTA Regulation - European Commission Publishes Implementing Regulation containing Procedures for Joint Scientific Consultations on Medicinal Products Briefings
HTA Regulation - European Commission Publishes Implementing Regulation containing Procedures for Joint Scientific Consultations on Medical Devices Briefings
Belgium To Lead Consortium To Assess Health Technologies Under Health Technology Assessment Regulation Briefings
The Netherlands - Leadiant Sees Excessive Pricing Decision Largely Confirmed By Rotterdam Court Briefings
Court of Justice of European Union Clarifies Concept of ‘Advertising of Medicinal Products’ Briefings
Belgian Competition Authority Accuses Roche of Hampering Biosimilar Market Entry in Oncology Briefings
European Commission Proposes Critical Medicines Act to Bolster Security of Supply of Critical Medicines Briefings
Belgium - Minister of Social Affairs and Public Health Presents Policy Declaration on Public Health in Parliament Briefings
Legal 500 EMEA 2025: VBB excels with 11 ranked practices, and multiple individual lawyers recognised News
Following European Commission UK CMA Also Concludes Procedure Against Vifor Obtaining Commitments but Not Finding Infringement Briefings
Bulgaria - Commission for Protection of Competition Begins Sector Inquiry of Wholesale and Retail Markets for Medicines Briefings
Belgian Competition Authority Carries Out On-Premise Inspections in Personal Care and Retail Sectors Briefings
Belgium Implements Health Technology Assessment Regulation for Medicines and Publishes related Q&A Briefings
European Commission Imposes Further Fine on Seventh Member of Cartel in Pharmaceutical Industry Briefings
Abusive Promotional & Regulatory Activities French Supreme Court Reinstates €444 Million Fines on Novartis, Roche and Genentech Briefings
VBB lawyers author Belgium chapter in the Chambers Digital Healthcare 2025 Global Practice Guide News
AbbVie Scores Major Win Defending its Humira® Pricing in the Netherlands Against Private Excessive Pricing Action Briefings
Informal Opinion of Belgian Competition Authority Finds Proposed Fee Regulation of Veterinarians' Association Incompatible with Competition Law Briefings
Parallel Trade in Medicines - New Request for Preliminary Ruling before European Court of Justice Briefings
European Commission Publishes Updated Guidelines on Variations to Marketing Authorisations for Human Medicinal Products Briefings
UK - Provisional Decision of CMA in Veterinary Sector Market Investigation Proposes Major Reforms Briefings
Belgian Federal Agency for Medicines and Health Products to Fast-track Clinical Trial Evaluations from January 2026 Briefings
HTA Regulation - European Commission Completes Regulatory Framework by Publishing Rules for Joint Clinical Assessments of Medical Devices Briefings
Alleged Excessive Pricing of Orphan Medicine - Swedish Competition Authority Closes Investigation Briefings
European Commission Publishes Implementing Regulations on Good Manufacturing Practice for Veterinary Medicinal Products and Active Substances Briefings
In Kwizda Pharma II, Court of Justice of European Union Provides Guidance on Application of Directive 2001/83/EC to Borderline Products Briefings
French Competition Authority Imposes Substantial Fine on Telemedicine Firm on Account of Abusive Conduct Briefings